medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2007, Número 1

<< Anterior Siguiente >>

Dermatología Cosmética, Médica y Quirúrgica 2007; 5 (1)


Granuloma candidósico en un paciente diabético: informe de un caso

Palacios YE, Villanueva RJ, Fernández R, Arenas R

Idioma: Español
Referencias bibliográficas: 44
Paginas: 44-49
Archivo PDF: 310.05 Kb.


RESUMEN

El granuloma candidósico es una infección mucocutánea por Candida Albicans que se presenta generalmente en la infancia y puede observarse con menor frecuencia en la etapa adulta. Las áreas más afectadas son cara, mucosa oral, cuero cabelludo y uñas. El tratamiento más efectivo es anfotericina B.
Se presenta el caso de un hombre de 41 años de edad con diabetes mellitus tipo 2, con dos lesiones nodulares ubicadas en la región del apéndice xifoides e hipocondrio derecho. En el cultivo se aislaron colonias de Candida Albicans y la citología mostró proceso inflamatorio granulomatoso. En la biopsia con tinción de PAS, se observó la presencia de hifas. Recibió tratamiento con anfotericina B e itraconazol con mejoría de la lesiones y negativización del estudio micológico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Rowell JL. Mucocutaneous candidiasis. Semin Perinatol 2003; 27 (5): 406-13

  2. Kugelman T, Derek J, Harrel R. Candida granuloma with epidermophytosis. Arch Dermatol 1963; 88: 150-157

  3. Kirkpatrick CH, Rich RR, Benett JE. Chronic mucocutaneous candidosis: Model building in cellular immunity. Ann Intern Med 1971; 74: 955-978

  4. Anstey A, Spickett G, Beechery-Newman N. A case of candidal umbilical granuloma. Br J Dermatol 1991: 124: 475-478

  5. Chiu SJ. Chronic mucocutaneous candidiasis in a 6-year-old boy. J Microbiol Immunol Infect 2004; 37 (3): 196-199

  6. Haynes K. Virulence in Candida species. Review Trends Microbiol. 2001; 12 (9): 591-595

  7. Drohuet E. Candidosis mucocutánea. Med Micol 2000; 8: 571-583

  8. Van G. Candida specific interferon gamma deficiency and toll like receptor polymorphisms in patients with chronic mucocutaneous candidiasis. Neth J Med 2003; 61 (11): 365-369

  9. Durandy A, Fisher A, Ledeist F. Mannan-specific and mannan induced T-cell suppressive activity in patients with chronic mucocutaneous candidosis. J Clin Immunol 1987; 7: 400-408

  10. Fisher A, Ballet J, Griscelli C. Specific inhibition of in vitro Candida induced lymphocytes proliferation by polysaccharides antigens present in the serum of patients with chronic mucocutaneous candidiasis. J Clin Invest 1978; 62: 1005-1013

  11. Buckeley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobinemia E and undue susceptibility to infection. Pediatrics 1972; 49: 59-70

  12. Buckley RH, Lucas ZJ, Hattler BG et al. Defective cellular immunity associated with chronic mucocutaneous moniliasis and recurrent staphylococcal botryomycosis: Immunological reconstitution by allogenic bone marrow. Clin Exp Immunol 1968; 3: 15-20

  13. Hill HR, Ochs HD, Quie P, et al. Defect in neutropenic granulocyte chemotaxis in Job’s syndrome of recurrent “cold” staphylococcal abscess. Lancet 1974; 2: 617-619

  14. López J. Mucocutaneous candidiasis as first manifestation of autoimmune polyglandular syndrome type. J Dent Child 2005; 72 (1): 21-4

  15. Myhre AG. Chronic mucocutaneous candidiasis and primary hypothyroidism in two families. Eur J Pediatr 2004; 163 (10): 604-611

  16. De Padova S, Chérie M, Kantor R. Candidiasis endocrinopathy syndrome. Arch Dermatol 1994; 130: 19-22

  17. Papazian C, Koch R. Monilia granuloma with hypothyroidism: Report of a case treated with amphotericin B. N Engl J Med 1960; 262: 16-18

  18. Lingelbach A. Chronic mucocutaneous candidosis with severe esophageal constricture. Mycoses 2003; 46: S 15-8

  19. Sathishkumar T. Chronic mucocutaneous candidiasis in a child. J Dermatol Venereol Leprol 2005; 71 (6): 432-433

  20. 20.Higgs JM, Wells RS. Chronic mucocutaneous candidiasis: New approaches to treatment. Br J Dermatol 1973; 89: 179-190

  21. Ro B. Chronic mucocutaneous candidosis. J Dermatol 1988; 27: 457-462

  22. Fajita M, Danno K, Ohno S. Two cases of diaper area granuloma of the adult. J Dermatol 1991; 18: 671-675

  23. Hassan G. Terbinafine effectiveness in ketoconazole resistant mucocutaneous candidiasis in polyglandular autoimmune syndrome type 1. J Assoc Physicians India 2003; 51: 323-326

  24. 24.Dupont B. An epidemiological review of systemic fungal infections. J Mycol Med 2002; 12: 163-173

  25. Seebacher C. Candida in dermatology. Mycoses 1999; S1: 63-67

  26. 26.Kalffa VC. The syndrome of chronic mucocutaneous candidiasis with selective antibody deficiency Ann Allergy Asthma. Immunol 2003; 90 (2): 259-64

  27. Ginter G, Rieger E, Stefan H. Granulomatous panniculitis caused by Candida albicans: A case presenting with multiple leg ulcers. J Am Acad Dermatol 1993; 28: 315-317

  28. Heimadahl A, Nord C. Oral yeast infections in immunocompromised and seriously diseased patients. Acta Odontol Scand 1990; 48: 77-84

  29. 29.Horshmaneimo M, Kai K, Virolainen M. Immunologic features of chronic granulomatous mucocutaneous candidiasis before and after treatment with transfer factor ARC. Dermatology 1979; 115: 169-178

  30. Santos P, Oleastro M, Galicchio M. Infecciones fúngicas en pacientes pediátricos con enfermedad granulomatosa crónica. Rev Iberoam Micol 2000; 17: 6-9

  31. Liu J. Histopathologic and scanning electron microscope examination of the nail and hair in chronic mucocutaneous candidiasis. J Am Acad Dermatol 2003; 49 (2): 154-156

  32. Jorgensen E. Histopathology, immunology and serology of oral yeast infections. Diagnosis of oral candidosis. Acta odontol Scand 190 (48): 37-43

  33. Venkita J, Andavolu H, Chin T. Granulomatous inflammation in the acquired immune deficiency syndrome. Am J Clin Pathol 1985; 84: 598-602

  34. Lilic D. Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis. Infect Immunol 2003; 71 (10): 5690-5699

  35. Robert R, Senté JM. Physiopathologie des candidosis. J Mycol Med 1995, 5: 145-166

  36. Frank O. Candida species and virulence. Features 1994; 190 (60): 313-318

  37. Dupont B, Drouhet E. Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients. J Med Vet Mycol 1988; 26: 67-71

  38. Albrech C, Martínez J. Sensibilidad al fluconazol y la anfotericina B en cepas de Candida provenientes de aislamientos clínicos. Rev Iberoam Micol 1998; 15: 298-299

  39. Budtz-Jorgensen E. Etiology, pathogenesis, therapy and prophylaxis of oral yeast infections. Acta Odontol Scand 1990; 48: 61-69

  40. 40.Campos J, Franco G, Hamdan J. Phenotypic and genotypic identification of Candida sp. isolated from hospitalized patients. Rev Iberoam Micol 2004; 21: 24-28

  41. Fontenay C, Lavielle B, Linas D. Comparaison statistique de deux méthodes d’évaluation de la activité antifongique. J Mycol Med 1996; 6: 129-132

  42. Ceballos A, Gaitán L. Resistencia in vitro a los antifúngicos en Cándida albicans de pacientes infectados por el VIH con o sin candidiosis [¿candidosis o candidiasis?] oral. Rev Iberoam Micol 1999; 16: 194-197

  43. Drohuet E, Dupont B. Laboratory and clinical assessment of ketoconazole in deep seated mycoses. Am J Med. 1983; 74: 30-47

  44. 44.Drouhet E, Dupont B. Chronic mucocutaneous candidosis and other superficial and systemic mycoses successfully treated with ketoconazole. Rev Infect Dis. 1980; 2: 606-619




2020     |     www.medigraphic.com